Hartland & Co »

Benitec Biopharma shares owned by Hartland & Co

Quarter-by-quarter ownership of Benitec Biopharma (BNTC) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Benitec Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Benitec Biopharma held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Benitec Biopharma by Hartland & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $54 4 13.50

More positions owned by Hartland & Co

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Apple Put Put Option (Principal) (AAPL)
Paccar (PCAR)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Value Etf (VTV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Spdr Index Shs Fds St Str Po Ex Etf (SPDW)
Amazon Call Call Option (AMZN)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Ishares Tr Core Msci Intl (IDEV)
Vanguard Index Fds Call Call Option (VTI)

View all positions for Hartland & Co

Top funds holding Benitec Biopharma

Suvretta Capital Management
Henderson Group
Jupiter Topco
Franklin Resources
Adage Capital Partners GP
RA Capital Management
Nantahala Capital Management
BlackRock
Simplify Asset Management
Vanguard Capital Management
Infinitum Asset Management
Millennium Management
Alyeska Investment Group
Silverarc Capital Management
Balyasny Asset Management

View all funds holding Benitec Biopharma